According to the accumulation of IPP within zoledronate-treated cancer cells, expanded Vγ9Vδ2 T cells expressed higher cytotoxic functions against zoledronate-treated cholangiocarcinoma cell lines compared to non-treated cells. Here, IPP is linked to cholangiocarcinoma.